SouthState Corp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Sell
7,422
-719
-9% -$101K 0.05% 199
2025
Q4
$999K Sell
8,141
-400
-5% -$48.6K 0.04% 203
2025
Q3
$948K Sell
8,541
-1,255
-13% -$143K 0.04% 199
2025
Q2
$1.09M Sell
9,796
-148
-1% -$15.8K 0.05% 192
2025
Q1
$1.11M Sell
9,944
-417
-4% -$43K 0.05% 189
2024
Q4
$957K Sell
10,361
-1,649
-14% -$148K 0.06% 152
2024
Q3
$1.01M Sell
12,010
-2,584
-18% -$197K 0.07% 147
2024
Q2
$1M Sell
14,594
-1,581
-10% -$106K 0.07% 142
2024
Q1
$1.18M Sell
16,175
-1,887
-10% -$145K 0.09% 127
2023
Q4
$1.46M Sell
18,062
-4,098
-18% -$319K 0.12% 117
2023
Q3
$1.66M Sell
22,160
-4,468
-17% -$344K 0.16% 110
2023
Q2
$2.05M Sell
26,628
-4,974
-16% -$397K 0.18% 103
2023
Q1
$2.62M Sell
31,602
-3,777
-11% -$313K 0.24% 94
2022
Q4
$3.04M Sell
35,379
-2,987
-8% -$237K 0.28% 89
2022
Q3
$2.37M Sell
38,366
-1,739
-4% -$110K 0.24% 96
2022
Q2
$2.48M Sell
40,105
-1,411
-3% -$87.4K 0.23% 96
2022
Q1
$2.47M Buy
41,516
+771
+2% +$49.3K 0.2% 103
2021
Q4
$2.96M Buy
40,745
+1,043
+3% +$71.8K 0.23% 99
2021
Q3
$2.77M Buy
39,702
+174
+0.4% +$12.2K 0.23% 95
2021
Q2
$2.72M Sell
39,528
-322
-0.8% -$21.5K 0.23% 94
2021
Q1
$2.58M Sell
39,850
-2,190
-5% -$141K 0.24% 92
2020
Q4
$2.45M Sell
42,040
-11,392
-21% -$687K 0.24% 90
2020
Q3
$3.38M Buy
53,432
+698
+1% +$48.4K 0.35% 73
2020
Q2
$4.06M Buy
52,734
+5,678
+12% +$435K 0.5% 57
2020
Q1
$3.52M Buy
47,056
+8,901
+23% +$615K 0.52% 58
2019
Q4
$2.48M Buy
38,155
+4,703
+14% +$306K 0.29% 88
2019
Q3
$2.12M Buy
+33,452
New +$2.19M 0.27% 90
2018
Q4
Sell
-3,451
Closed -$267K 256
2018
Q3
$267K Sell
3,451
-3,949
-53% -$298K 0.03% 238
2018
Q2
$524K Sell
7,400
-322
-4% -$22.7K 0.06% 189
2018
Q1
$582K Sell
7,722
-665
-8% -$52.9K 0.07% 176
2017
Q4
$601K Sell
8,387
-2,442
-23% -$185K 0.06% 197
2017
Q3
$877 Sell
10,829
-409
-4% -$31.3K 0.1% 138
2017
Q2
$795K Sell
11,238
-1,266
-10% -$84.2K 0.1% 143
2017
Q1
$850K Buy
12,504
+6,074
+94% +$427K 0.11% 141
2016
Q4
$461K Sell
6,430
-16,234
-72% -$1.21M 0.07% 172
2016
Q3
$1.79M Buy
22,664
+166
+0.7% +$13.5K 0.27% 98
2016
Q2
$1.88M Sell
22,498
-4,970
-18% -$441K 0.28% 94
2016
Q1
$2.52M Sell
27,468
-722
-3% -$65.1K 0.39% 85
2015
Q4
$2.85M Buy
28,190
+917
+3% +$95.4K 0.45% 81
2015
Q3
$2.68M Buy
27,273
+3,347
+14% +$372K 0.41% 84
2015
Q2
$2.8M Buy
23,926
+6,417
+37% +$701K 0.39% 84
2015
Q1
$1.72M Buy
17,509
+14,107
+415% +$1.43M 0.24% 115
2014
Q4
$321K Sell
3,402
-1,236
-27% -$128K 0.05% 198
2014
Q3
$494K Buy
4,638
+1,400
+43% +$137K 0.08% 181
2014
Q2
$269K Sell
3,238
-75
-2% -$5.84K 0.04% 227
2014
Q1
$235K Buy
3,313
+354
+12% +$27.8K 0.04% 242
2013
Q4
$222K Buy
+2,959
New +$206K 0.04% 244

Other funds holding GILD

SouthState Corp's GILD Position: Q1 2026 in Review

SouthState Corp reduced its Gilead Sciences (GILD) stake by 8.8% in Q1 2026, selling an estimated $101K and leaving 7,422 shares worth $1.03M. The position accounts for 0.05% of the portfolio, ranked #199.

SouthState Corp first reported a position in GILD in Q4 2013 and has held it in 47 quarters since. The position peaked at $4.06M in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • SouthState Corp held 7,422 shares of Gilead Sciences worth $1.03M as of Q1 2026.
  • SouthState Corp sold 719 Gilead Sciences shares in Q1 2026, an estimated $101K.
  • Gilead Sciences made up 0.05% of SouthState Corp's portfolio in Q1 2026, its #199 holding.
  • SouthState Corp first reported a position in Gilead Sciences in Q4 2013 and has held it in 47 quarters since.
  • SouthState Corp's Gilead Sciences position peaked at $4.06M in Q2 2020.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.